Literature DB >> 16889062

[Derivatives of exemestane--synthesis and evaluation of aromatase inhibition].

K Görlitzer1, Ch Bonnekessel, P G Jones, A Palusczak, R W Hartmann.   

Abstract

The irreversible aromatase inhibitor exemestane (6) reacts with nitromethane and sodium ethanolate to yield the Michael adduct 9. The aldehyde 10 is obtained by Nef reaction of the nitro compound 9 and affords the 1,4-dihydropyridine (DHP) 11 by Hantzsch reaction using methyl beta-aminocrotonate in acetic acid. The new compounds showed a reduced inhibitory potency towards aromatase (IC50 values: 9, 0.91 microM; 10, 2.5 microM; 11, 10 microM) compared to 6 (IC50 = 0.23 microM). The 1,4-DHP 11 was dehydrogenated with CAN or electrochemically (E1/2 =1.18 V) to yield the corresponding pyridine 12.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16889062

Source DB:  PubMed          Journal:  Pharmazie        ISSN: 0031-7144            Impact factor:   1.267


  3 in total

Review 1.  Human cytochrome P450 enzymes 5-51 as targets of drugs and natural and environmental compounds: mechanisms, induction, and inhibition - toxic effects and benefits.

Authors:  Slobodan P Rendic; F Peter Guengerich
Journal:  Drug Metab Rev       Date:  2018-08       Impact factor: 4.518

2.  Microbial transformation of anti-cancer steroid exemestane and cytotoxicity of its metabolites against cancer cell lines.

Authors:  Elias Baydoun; Marium Bibi; Muhammad Asif Iqbal; Atia-Tul Wahab; Dina Farran; Colon Smith; Samina A Sattar; Atta-Ur Rahman; M Iqbal Choudhary
Journal:  Chem Cent J       Date:  2013-03-27       Impact factor: 4.215

3.  Crystal engineering of exemestane to obtain a co-crystal with enhanced urease inhibition activity.

Authors:  Syeda Saima Fatima; Rajesh Kumar; M Iqbal Choudhary; Sammer Yousuf
Journal:  IUCrJ       Date:  2020-01-01       Impact factor: 4.769

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.